National Research Corporation (NRC) Financials
NRC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 120.1 million | 62.3 million |
| 2023-06-30 | 133.6 million | 55.9 million |
| 2023-03-31 | 134.3 million | 59.6 million |
NRC Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 5.3 million | 68000 |
| 2023-06-30 | 4.5 million | 305000 |
| 2023-03-31 | 4.6 million | 304000 |
NRC Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 8.9 million |
| 2023-09-30 | 7.9 million |
| 2023-06-30 | 7.3 million |
| 2023-03-31 | 7.0 million |
NRC Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 3.8 million | - | - |
| 2023-06-30 | 22.5 million | 15.4 million | - |
| 2023-03-31 | 23.7 million | 16.5 million | - |
NRC Shares Outstanding
NRC Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 4.5 million | - | 11.8 million | - |
| 2023-06-30 | 4.3 million | - | 3.0 million | - |
| 2023-03-31 | 3.2 million | - | 3.0 million | - |
NRC Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-09-30 | 37.9 million | 14.6 million |
| 2023-06-30 | 36.2 million | 13.3 million |
| 2023-03-31 | 36.5 million | 14.3 million |
NRC
Price: $32.87
Dividend Yield: 0.01%
Forward Dividend Yield: 1.46%
Payout Ratio: 41.38%
Dividend Per Share: 0.48 USD
Earnings Per Share: 1.25 USD
P/E Ratio: 32.23
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Volume: 12200
Market Capitalization: 844.7 million
Average Dividend Frequency: 4
Years Paying Dividends: 21
DGR3: -30.00%
DGR5: -28.87%